A new vaccine out of the University of Adelaide uses a particular DNA protein to trigger an immune response in the bodies of those affected by HIV and Hepatitis C.
The protein in the vaccine causes a small amount of cell death at the point of vaccination, activating dendritic cells, or ‘messenger’ white blood cells, which are highly concentrated in the skin and which play an important role in fighting infection. The environment created by the arrival of these cells in turn allows the vaccine to thrive in the body. The overall effect is a boost in the immune system.
The technique is still in the pre-clinical phase, but has the potential to work against other more common viruses in addition to HIV and Hepatitis C.
Professor Eric Gowans from the university said, “We’re now ready for a commercial partner to help us take this to the next phase”.
[img source] Microscopyu.com via bit.ly/1n57FYF